Center for Global Health Policy’s “Science Speaks”: Children, people with HIV, pregnant women, and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say
Antigone Barton, senior editor and writer of “Science Speaks,” discusses “an article [published] in a recently released Journal of Infectious Diseases supplement on tuberculosis drug development [that] explores the challenges [of] developing products of appropriate doses and formulations for children, people with HIV, people with diabetes, and pregnant women, as well as the opportunities that meeting those challenges present…” (6/1).